UK patients rush to buy obesity jab ahead of 170% price rise
Asda warns of ‘difficult situation’ after US drugmaker Eli Lilly responds to pressure from Donald Trump
Related reading
US to slash prices of obesity drugs offered on Trump website
White House’s landmark deal with Novo Nordisk and Eli Lilly will cut costs from at least $1,000 to about $350
Britain is squeezing AstraZeneca too tight
NHS curbs on drug prices have alienated UK pharma companies and become self-defeating
Eli Lilly raises UK price of weight-loss drug Mounjaro by up to 170%
Pharma group seeks to address US complaints about ‘foreign freeloaders’ who rely on Americans to pay more for medicines
Eli Lilly shot helped patients lose 29% of body weight
Trial results are a boost to US pharmaceutical company’s booming obesity business
US set to speed up approval for some generic drugs in blow to Big Pharma
Move is latest broadside by Trump administration against pharmaceuticals industry that fought to derail changes
Weight-loss weariness and Trump threats wipe $250bn off Novo Nordisk and Eli…
Trump’s push for price cuts and tariffs weighs on ‘obesity franchises’, which have missed out on equity market’s rise